[1]
|
Brandt, M.E., Hutwagner, L.C., Klug, L.A., Baughman, W.S., Rimland, D., Gravis, E.A., Hamill, R.J., Thomas, C., Pappas, P.G., Reingold, A.L. and Pinner, R.W. (1996) Molecular Subtype Distribution of Cryptococcus neoformans in Four Areas of the United States. Cryptococcal Disease Active Surveillance Group. Journal of Clinical Microbiology, 34, 912-917.
|
[2]
|
Iqbal, N., DeBess, E.E., Wohrle, R., Sun, B., Nett, R.J., Ahlquist, A.M., Chiller, T., Lockhart, S.R., et al. (2010) Correlation of Genotype and In Vitro Susceptibilities of Cryptococcus gattii Strains from the Pacific Northwest of the United States. Journal of Clinical Microbiology, 48, 539-544. https://doi.org/10.1128/JCM.01505-09
|
[3]
|
Kurtzman, C.P., Fell, J.W. and Boekhout, T. (2011) The Yeasts: A Taxonomic Study. 5th Edition, ACM Press, NY.
|
[4]
|
Emmons C.W. ,et al. (1951)Isolation of Cryptococcus neoformans from Soil Journal of Bacteriology 62, 685-690.
|
[5]
|
Emmons, C.W. (1955) Saprophytic Sources of Cryptococcus neoformans Associated with the Pigeon (Columba livia). American Journal of Hygiene, 62, 227-232. https://doi.org/10.1093/oxfordjournals.aje.a119775
|
[6]
|
Baroni, F.A., Paula, C.R., Silva, E.G., Viani, F.C., Rivera, I.N., Oliveira, M.T.B. and Gabale, W. (2006) Cryptococcus neoformans Strains Isolated from Church Towers in Rio de Janeiro City, RJ, Brazil. The Revista do Instituto de Medicina Tropical de São Paulo, 48, 71-75. https://doi.org/10.1590/S0036-46652006000200003
|
[7]
|
Lin, X. and Heitman, J. (2006) The Biology of the Cryptococcus neoformans Species Complex. Annual Review of Microbiology, 60, 69-105. https://doi.org/10.1146/annurev.micro.60.080805.142102
|
[8]
|
Klein, K.R., Hall, L., Deml, S.M., Rysavy, J.M., Wohlfiel, S.L. and Wengenack, N.L. (2009) Identification of Cryptococcus gattii by Use of L-Canavanine Glycine Bromothymol Blue Medium and DNA Sequencing. Journal of Clinical Microbiology, 47, 3669-3672. https://doi.org/10.1128/JCM.01072-09
|
[9]
|
Kwon-Chung, K.J., Polacheck, I. and Bennett, J.E. (1982) Improved Diagnostic Medium for Separation of Cryptococcus neoformans var. neoformans (Serotypes A and D) and Cryptococcus neoformans var. gattii (Serotypes B and C). Journal of Clinical Microbiology, 15, 535-537.
|
[10]
|
Ellis, D., Marriott, D., Hajjeh, R.A., Warnock, D., Meyer, W. and Barton, R. (2000) Epidemiology: Surveillance of Fungal Infections. Medical Mycology, 38, 173-182. https://doi.org/10.1080/mmy.38.s1.173.182
|
[11]
|
Meyer, W., Castañeda, A., Jackson, S., Huynh, M., Castañeda, E., et al. (2003) Molecular Typing of IberoAmerican Cryptococcus neoformans Isolates. Emerging Infectious Diseases, 9, 189-195. https://doi.org/10.3201/eid0902.020246
|
[12]
|
Silva, D.C., Martins, M.A., Szeszs, M.W., Bonfietti, L.X., Matos, D. and Melhem, M.S. (2012) Susceptibility to Antifungal Agents and Genotypes of Brazilian Clinical and Environmental Cryptococcus gattii Strains. Diagnostic Microbiology and Infectious Disease, 72, 332-339. https://doi.org/10.1016/j.diagmicrobio.2011.11.016
|
[13]
|
Diaz, M.R., Boekhout, T., Kiesling, T. and Fell, J.W. (2005) Comparative Analysis of the Intergenic Spacer Regions and Population Structure of the Species Complex of the Pathogenic Yeast Cryptococcus neoformans. FEMS Yeast Research, 5, 1129-1140. https://doi.org/10.1016/j.femsyr.2005.05.005
|
[14]
|
Boekhout, T., Theelen, B., Diaz, M., Fell, J.W., Hop, W.C., Abeln, E.C., Dromer, F. and Meyer, W. (2001) Hybrid Genotypes in the Pathogenic Yeast Cryptococcus neoformans. Microbiology, 147, 891-907. https://doi.org/10.1099/00221287-147-4-891
|
[15]
|
Kidd, S.E., Guo, H., Bartlett, K.H., Xu, J. and Kronstad, J.W. (2005) Comparative Gene Genealogies Indicate that Two Clonal Lineages of Cryptococcus gattii in British Columbia Resemble Strains from Other Geographical Areas. Eukaryotic Cell, 4, 1629-1638. https://doi.org/10.1128/EC.4.10.1629-1638.2005
|
[16]
|
Fraser, J.A., Giles, S.S., Wenink, E.C., Geunes-Boyer, S.G., Wright, J.R., Diezmann, S., Allen, A., Stajich, J.E., Dietrich, F.S., Perfect, J.R. and Heitman, J. (2005) Same-Sex Mating and the Origin of the Vancouver Island Cryptococcus gattii Outbreak. Nature, 437, 1360-1364. https://doi.org/10.1038/nature04220
|
[17]
|
Steenbergen, J.N. and Casadevall, A. (2003) The Origin and Maintenance of Virulence for the Human Pathogenic Fungus Cryptococcus neoformans. Microbes and Infection, 5, 667-675. https://doi.org/10.1016/S1286-4579(03)00092-3
|
[18]
|
Chang, Y.C. and Kwon-Chung, K.J. (1994) Complementation of a Capsule-Deficient Mutation of Cryptococcus neoformans Restores Its Virulence. Molecular and Cellular Biology, 14, 4912-4919. https://doi.org/10.1128/MCB.14.7.4912
|
[19]
|
Rivera, J., Feldmesser, M., Cammer, M. and Casadevall, A. (1998) Organ-Dependent Variation of Capsule Thickness in Cryptococcus neoformans during Experimental Murine Infection. Infection and Immunity, 66, 5027-5030.
|
[20]
|
Zaragoza, O., Rodrigues, M.L., De Jesus, M., Frases, S., Dadachova, E. and Casadevall, A. (2009) The Capsule of the Fungal Pathogen Cryptococcus neoformans. Advances in Applied Microbiology, 68, 133-216. https://doi.org/10.1016/S0065-2164(09)01204-0
|
[21]
|
Wang, Y., Aisen, P. and Casadevall, A. (1995) Cryptococcus neoformans Melanin and Virulence: Mechanism of Action. Infection and Immunity, 63, 3131-3136.
|
[22]
|
Cox, G.M., Mukherjee, J., Cole, G.T., Casadevall, A. and Perfect, J.R. (2000) Urease as a Virulence Factor in Experimental Cryptococcosis. Infection and Immunity, 68, 443-448. https://doi.org/10.1128/IAI.68.2.443-448.2000
|
[23]
|
Cox, G.M., McDade, H.C., Chen, S.C., Tucker, S.C., Gottfredsson, M., Wright, L.C., Sorrell, T.C., Leidich, S.D., Casadevall, A., Ghannoum, M.A. and Perfect, J.R. (2001) Extracellular Phospholipase Activity Is a Virulence Factor for Cryptococcus neoformans. Molecular Microbiology, 39, 166-175.
|
[24]
|
Liu, G.Y. and Nizet, V. (2009) Color Me Bad: Microbial Pigments as Virulence Factors. Trends in Microbiology, 17, 406-413.
|
[25]
|
Moraes, E.M., Prímola, N.S. and Hamdan, J.S. (2003) Antifungal Susceptibility of Clinical and Environmental Isolates of Cryptococcus neoformans to Four Antifungal Drugs Determined by Two Techniques. Mycoses, 46, 164-168. https://doi.org/10.1046/j.1439-0507.2003.00872.x
|
[26]
|
Souza, L.K., Fernandes, O.F., Kobayashi, C.C., Passos, X.S., Costa, C.R., Lemos, J.A, Souza-Jr., H.S. and Silva, M.R.R. (2005) Antifungal Susceptibilities of Clinical and Environmental Isolates of Cryptococcus neoformans in Goiania City, Goiás, Brazil. The Revista do Instituto de Medicina Tropical de São Paulo, 47, 253-256. https://doi.org/10.1590/S0036-46652005000500003
|
[27]
|
Chowdhary, A., Randhawa, H.S., Sundar, G., Kathuria, S., Prakash, A., Khan, Z, Sun, S. and Xu, J. (2011) In Vitro Antifungal Susceptibility Profiles and Genotypes of 308 Clinical and Environmental Isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii Serotype B from Northwestern India. Journal of Medical Microbiology, 60, 961-967. https://doi.org/10.1099/jmm.0.029025-0
|
[28]
|
Martins, M.A., Pappalardo, M.C., Melhem, M.S. and Pereira-Chioccola, V.L. (2007) Molecular Diversity of Serial Cryptococcus neoformans Isolates from AIDS Patients in the City of São Paulo, Brazil. The Memórias do Instituto Oswaldo Cruz, 102, 777-784. https://doi.org/10.1590/S0074-02762007000700001
|
[29]
|
Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. 2nd Edition, Cold Spring Harbor Laboratory Press, New York.
|
[30]
|
Macdougall, L., Kidd, S.E., Galanis, E., Mak, S., Leslie, M.J., Cieslak, P.R., Kronstad, J.W., Morsehed, M.G. and Bartlett, K.H. (2007) Spread of Cryptococcus gattii in British Columbia, Canada, and Detection in the Pacific Northwest, USA. Emergent Infectious Diseases Journal, 13, 42-50. https://doi.org/10.3201/eid1301.060827
|
[31]
|
Rüchel, R., Tegeler, R. and Trost, M. (1982) A Comparison of Secretory Proteinases from Different Strains of Candida albicans. Sabouraudia, 20, 233-244. https://doi.org/10.1080/00362178285380341
|
[32]
|
Price, M.F., Wilkinson, I.D. and Gentry, L.O. (1982) Plate Method for Detection of Phospholipase Activity in Candida albicans. Sabouraudia, 20, 7-14. https://doi.org/10.1080/00362178285380031
|
[33]
|
Lozano-Chiu, M., Paetznick, V.L., Ghannoum, M.A. and Rex, J.H. (1998) Detection of Resistance to Amphotericin B among Cryptococcus neoformans Clinical Isolates: Performances of Three Different Media Assessed by Using E-Test and National Committee for Clinical Laboratory Standards M27-A Methodologies. Journal of Clinical Microbiology, 36, 2817-2822.
|
[34]
|
Pfaller, M.A., Messer, S.A., Houston, A., Mills, K., Bolmstrom, A. and Jones, R.N. (2000) Evaluation of the Etest Method for Determining Voriconazole Susceptibilities of 312 Clinical Isolates of Candida Species by Using Three Different Agar Media. Journal of Clinical Microbiology, 38, 3715-3717.
|
[35]
|
Clinical and Laboratory Standards Institute (2012) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. 4th Informational Supplement, CLSI Document M27-S4, Clinical and Laboratory Standards Institute, Wayne, PA.
|
[36]
|
Kumar, D., Bhattacharyya, S., Gupta, P., Banerjee, G. and Singh, M. (2015) Comparative Analysis of Disc Diffusion and E-Test with Broth Micro-Dilution for Susceptibility Testing of Clinical Candida Isolates against Amphotericin B, Fluconazole, Voriconazole and Caspofungin. Journal of Clinical and Diagnostic Research, 9, DC01-DC04.
|
[37]
|
Franzot, S.P., Salkin, I.F. and Casadevall, A. (1999) Cryptococcus neoformans var. grubii: Separate Varietal Status for Cryptococcus neoformans Serotype A Isolates. Journal of Clinical Microbiology, 37, 838-840.
|
[38]
|
Heitman, J. (2011) Microbial Pathogens in the Fungal Kingdom. Fungal Biology Reviews, 25, 48-60. https://doi.org/10.1016/j.fbr.2011.01.003
|
[39]
|
Hagen, F., Khayhan, K., Theelen, B., Kolecka, A., Polacheck, I., Sionov, E., Falk, R., Parnmen, S., Lumbsch, H.T. and Boekhout, T. (2015) Recognition of Seven Species in the Cryptococcus gattii/Cryptococcus neoformans Species Complex. Fungal Genetics and Biology, 78, 16-48. https://doi.org/10.1016/j.fgb.2015.02.009
|
[40]
|
Polacheck, I. and Kwon-Chung, K.J. (1986) Canavanine Resistance in Cryptococcus neoformans. Antimicrobial Agents and Chemotherapy, 29, 468-473. https://doi.org/10.1128/AAC.29.3.468
|
[41]
|
Nakamura, Y., Kano, R., Sato, H., Watanabe, S., Takahashi, H. and Hasegawa, A. (1998) Isolates of Cryptococcus neoformans Serotype A and D Developed on Canavanine-Glycine-Bromthymol Blue Medium. Mycoses, 41, 35-40.
|
[42]
|
Khan, Z.U., Al-Anezi, A.A., Chandy, R. and Xu, J. (2003) Disseminated Cryptococcosis in an AIDS Patient Caused by A Canavanine-Resistant Strain of Cryptococcus neoformans var. grubii. Journal of Medical Microbiology, 52, 271-275. https://doi.org/10.1099/jmm.0.05097-0
|
[43]
|
Casadevall, A. and Perfect, J.R. (1998) Cryptococcus neoformans. ASM Press, Washington DC.
|
[44]
|
Vidotto, V., Sinicco, A., Di Fraia, D., Cardaropoli, S., Aoki, S. and Ito-Kuwa, S. (1996) Phospholipase Activity in Cryptococcus neoformans. Mycopathologia, 136, 119-123. https://doi.org/10.1007/BF00438916
|
[45]
|
Chen, S.C., Muller, M., Zhou, J.Z., Wright, L.C. and Sorrell, T.C. (1997) Phospholipase Activity in Cryptococcus neoformans: A New Virulence Factor? The Journal of Infectious Diseases, 175, 414-420. https://doi.org/10.1093/infdis/175.2.414
|
[46]
|
Titball R.W. ,et al. (1993)Bacterial Phospholipases C Microbiological Reviews 57, 347-366.
|
[47]
|
Cardoso, P.H.M., dos Santos, R.L.O., Souza, A.C., Baroni, F.A., Domaneschi, C. and Paula, C.R. (2018) Biosynthesis of Phospholipases and Proteinases Using Clinical and Environmental Strains of Cryptococcus neoformans. Clinical and Laboratorial Research in Dentistry, 1, 1-5. http://dx.doi.org/10.11606/issn.2357-8041.clrd.2018.133520
|
[48]
|
Ghannoum, M.A. (2000) Potential Role of Phospholipases in Virulence and Fungal Pathogenesis. Clinical Microbiology Reviews, 13, 122-143. https://doi.org/10.1128/CMR.13.1.122-143.2000
|
[49]
|
Schmiel, D.H. and Miller, V.L. (1999) Bacterial Phospholipases and Pathogenesis. Microbes and Infection, 1, 1103-1112. https://doi.org/10.1016/S1286-4579(99)00205-1
|
[50]
|
Barrett-Bee, K., Hayes, Y., Wilson, R.G. and Ryley, J.F. (1985) A Comparison of Phospholipase Activity, Cellular Adherence and Pathogenicity of Yeasts. Journal of General Microbiology, 131, 1217-1221. https://doi.org/10.1099/00221287-131-5-1217
|
[51]
|
Ibrahim, A.S., Mirbod, F., Filler, S.G., Banno, Y., Cole, G.T., Kitajima, Y., Edwards-Jr., J.E., Nozawa, Y. and Ghannoum, M.A. (1995) Evidence Implicating Phospholipase as a Virulence Factor of Candida albicans. Infection and Immunity, 63, 1993-1998.
|
[52]
|
Birch, M., Robson, G., Law, D. and Denning, D.W. (1996) Evidence of Multiple Extracellular Phospholipase Activities of Aspergillus fumigatus. Infection and Immunity, 64, 751-755.
|
[53]
|
Levitz S.M. ,et al. (1991)The Ecology of Cryptococcus neoformans and the Epidemiology of Cryptococcosis Reviews of Infectious Diseases 13, 1163-1169.
|
[54]
|
Li, A., Nishimura, K., Taguchi, H., Tanaka, R., Wu, S. and Miyaji, M. (1993) The Isolation of Cryptococcus neoformans from Pigeon Droppings and Serotyping of Naturally and Clinically Sourced Isolates in China. Mycopathologia, 124, 1-5. https://doi.org/10.1007/BF01103049
|
[55]
|
Pappalardo, M.C. and Melhem, M.S. (2003) Cryptococcosis: A Review of the Brazilian Experience for the Disease. The Revista do Instituto de Medicina Tropical de São Paulo, 45, 299-305. https://doi.org/10.1590/S0036-46652003000600001
|
[56]
|
Soares, M.C., Paula, C.R., Dias, A.L., Caseiro, M.M. and Costa, S.O.P. (2005) Environmental Strains of Cryptococcus neoformans Variety grubii in the City of Santos, SP, Brazil. The Revista do Instituto de Medicina Tropical de São Paulo, 47, 31-36. https://doi.org/10.1590/S0036-46652005000100006
|
[57]
|
Kwon-Chung, K.J., Fraser, J.A., Doering, T.L., Wang, Z., Idnurm, A. and Bahn, Y.S. (2014) Cryptococcus neoformans and Cryptococcus gattii, the Etiologic Agents of Cryptococcosis. Cold Spring Harbor Perspectives in Medicine, 4, a019760. https://doi.org/10.1101/cshperspect.a019760
|
[58]
|
Ajello L. ,et al. (1958)Ocurrence of Cryptococcus neoformans in Solis American Journal of Hygiene 67, 72-77.
|
[59]
|
Lazera, M.S., Salmito Cavalcanti, M.A., Londero, A.T., Trilles, L., Nishikawa, M.M. and Wanke, B. (2000) Possible Primary Ecological Niche of Cryptococcus neoformans. Medical Mycology, 38, 379-383. https://doi.org/10.1080/mmy.38.5.379.383
|
[60]
|
Escandón, P., Sánchez, A., Martínez, M., Meyer, W. and Castañeda, E. (2006) Molecular Epidemiology of Clinical and Environmental Isolates of the Cryptococcus neoformans Species Complex Reveals a High Genetic Diversity and the Presence of the Molecular Type VGII Mating Type an in Colombia. FEMS Yeast Research, 6, 625-635. https://doi.org/10.1111/j.1567-1364.2006.00055.x
|
[61]
|
Refojo, N., Perrotta, D., Brudny, M., Abrantes, R., Hevia, A.I. and Davel, G. (2009) Isolation of Cryptococcus neoformans and Cryptococcus gattii from Trunk Hollows of Living Trees in Buenos Aires City, Argentina. Medical Mycology, 47, 177-184. https://doi.org/10.1080/13693780802227290
|
[62]
|
Ellis, D.H. and Pfeiffer, T.J. (1990) Natural Habitat of Cryptococcus neoformans var. gattii. Journal of Clinical Microbiology, 28, 1642-1644.
|
[63]
|
Montenegro, H. and Paula, C.R. (2000) Environmental Isolation of Cryptococcus neoformans var. gattii and C. neoformans var. neoformans in the City of São Paulo, Brazil. Medical Mycology, 38, 385-390. https://doi.org/10.1080/mmy.38.5.385.390
|
[64]
|
Casali, A.K., Goulart, L., Rosa e Silva, L.K., Ribeiro, A.M., Amaral, A.A., Alves, S.H., Schrank, A., Meyer, W. and Vainsteins, M.H. (2003) Molecular Typing of Clinical and Environmental Cryptococcus neoformans Isolates in the Brazilian State Rio Grande do Sul. FEMS Yeast Research, 3, 405-415. https://doi.org/10.1016/S1567-1356(03)00038-2
|
[65]
|
Granados, D.P. and Castañeda, E. (2006) Influence of Climatic Conditions on the Isolation of Members of the Cryptococcus neoformans Species Complex from Trees in Colombia from 1992-2004. FEMS Yeast Research, 6, 636-644. https://doi.org/10.1111/j.1567-1364.2006.00090.x
|
[66]
|
Mitchell, T.G., Castaneda, E., Niersen, K. and Wanke, B.M.S.L. (2011) Environmental Niches for Cryptococcus neoformans and Cryptococcus gattii. In: Heitman, J., et al., Eds., Cryptococcus: From Human Pathogen to Model Yeast, ASM Press, Washington DC, 237-259.
|
[67]
|
Berg, J., Clancy, C.J. and Nguyen, M.H. (1998) The Hidden Danger of Primary Fluconazole Prophylaxis for Patients with AIDS. Clinical Infectious Diseases, 26, 186-187. https://doi.org/10.1086/517056
|
[68]
|
Brandt, M.E., Pfaller, M.A., Hajjeh, R.A., Hamill, R.J., Pappas, P.G., Reingold, A.L., Rimland, D. and Warnock, D.W. (2001) Cryptococcal Disease Active Surveillance Group. Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrobial Agents and Chemotherapy, 45, 3065-3069. https://doi.org/10.1128/AAC.45.11.3065-3069.2001
|
[69]
|
Dias, A.L., Matsumoto, F.E., Melhem, M.S., Silva, E.G., Auler, M.E., Siqueira, A.M. and Paula, C.R. (2006) Comparative Analysis of Etest and Broth Microdilution Method (AFST-EUCAST) for Trends in Antifungal Drug Susceptibility Testing of Brazilian Cryptococcus neoformans Isolates. Journal of Medical Microbiology, 55, 1693-1699. https://doi.org/10.1099/jmm.0.46789-0
|
[70]
|
Matsumoto, F.E., Dias, A.L., Melhem, M.S., Szeszs, M.W., Auler, M.E., Ruiz, L.S., Gonçalves da Silva, E., Gandra, R.F. and Paula, C.R. (2007) Antifungal Susceptibility of Bloodstream Yeasts Isolated at a Public Children’s Hospital in Brazil: Comparison of the Etest®; and the AFST-EUCAST Microdilution Method. Canadian Journal of Microbiology, 53, 1300-1306. https://doi.org/10.1139/W07-095
|
[71]
|
Tewari, A., Behera, B., Mathur, P. and Xess, I. (2012) Comparative Analysis of the Vitek 2 Antifungal Susceptibility System and E-Test with the CLSI M27-A3 Broth Microdilution Method for Susceptibility Testing of Indian Clinical Isolates of Cryptococcus neoformans. Mycopathologia, 173, 427-433. https://doi.org/10.1007/s11046-012-9528-9
|
[72]
|
Mahabeer, Y., Chang, C.C., Naidu, D., Dorasamy, A., Lewin, S., Ndung’u, T., Moosa, M.Y., French, M., Mlisana, K. and Coovadia, Y. (2014) Comparison of Etests and Vitek 2® to Broth Microdilution for the Susceptibility Testing of Cryptococcus neoformans. Diagnostic Microbiology and Infectious Disease, 80, 294-298. https://doi.org/10.1016/j.diagmicrobio.2014.09.006
|
[73]
|
Negri, M., Henriques, M., Svidzinski, T.I., Paula, C.R. and Oliveira, R. (2009) Correlation between Etest, Disk Diffusion, and Microdilution Methods for Antifungal Susceptibility Testing of Candida Species from Infection and Colonization. Journal of Clinical Laboratory Analysis, 23, 324-330. https://doi.org/10.1002/jcla.20337
|
[74]
|
Ghannoum, M.A., Ibrahim, A.S., Fu, Y., Shafig, M.C., Edwards Jr., J.E. and Criddle, R.S. (1992) Susceptibility Testing of Cryptococcus neoformans: A Microdilution Technique. Journal of Clinical Microbiology, 30, 2881-2886.
|
[75]
|
Witt, M.D., Lewis, R.J., Larsen, R.A., Milefchik, E.N., Leal, M.A., Haubrich, R.H., Richie, J.A., Edwards Jr., J.E. and Ghannoum, M.A. (1996) Identification of Patients with Acute AIDS-Associated Cryptococcal Meningitis who Can Be Effectively Treated with Fluconazole: The Role of Antifungal Susceptibility Testing. Clinical Infectious Diseases, 22, 322-328. https://doi.org/10.1093/clinids/22.2.322
|
[76]
|
Alves, S.H., Oliveira, L.T., Costa, J.M., Lubeck, I., Casali, A.K. and Vainstein, M.H. (2001) In Vitro Susceptibility to Antifungal Agents of Clinical and Environmental Cryptococcus neoformans Isolated in Southern of Brazil. The Revista do Instituto de Medicina Tropical de São Paulo, 43, 267-270. https://doi.org/10.1590/S0036-46652001000500006
|
[77]
|
Bii, C.C., Makimura, K., Abe, S., Taguchi, H., Mugasia, O.M., Revathi, G., Wamae, N.C. and Kamiya, S. (2007) Antifungal Drug Susceptibility of Cryptococcus neoformans from Clinical Sources in Nairobi, Kenya. Mycoses, 50, 25-30. https://doi.org/10.1111/j.1439-0507.2006.01293.x
|
[78]
|
Capoor, M.R., Mandal, P., Deb, M., Aggarwal, P. and Banerjee, U. (2008) Current Scenario of Cryptococcosis and Antifungal Susceptibility Pattern in India: A Cause for Reappraisal. Mycoses, 51, 258-265. https://doi.org/10.1111/j.1439-0507.2007.01478.x
|
[79]
|
Thompson, G.R., Wiederhold, N.P., Fothergill, A.W., Vallor, A.C., Wickes, B.L. and Petterson, T.F. (2009) Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans. Antimicrobial Agents and Chemotherapy, 53, 309-311. https://doi.org/10.1128/AAC.01216-08
|
[80]
|
Tomazin, R., Matos, T., Meis, J.F. and Hagen, F. (2018) Molecular Characterization and Antifungal Susceptibility Testing of Sequentially Obtained Clinical Cryptococcus deneoformans and Cryptococcus neoformans Isolates from Ljubljana, Slovenia. Mycopathologia, 183, 371-380. https://doi.org/10.1007/s11046-017-0214-9
|